All Stories

  1. Non-Hodgkin Lymphomas

    Article • June 2014, Wiley

    Professor Ian T Magrath

  2. Cancer in Adolescents and Young Adults in Countries with Limited Resources

    Article • Current Oncology Reports, July 2013, Springer Science + Business Media

    Professor Ian T Magrath

  3. Planning cancer control—the view of an NGO

    Article • The Lancet Oncology, April 2013, Elsevier

    Professor Ian T Magrath

  4. Paediatric cancer in low-income and middle-income countries

    Article • The Lancet Oncology, March 2013, Elsevier

    Professor Ian T Magrath

  5. New policies to address the global burden of childhood cancers

    Article • The Lancet Oncology, March 2013, Elsevier

    Professor Ian T Magrath

  6. An Introduction to Burkitt Lymphoma

    Article • October 2012, Springer Science + Business Media

    Professor Ian T Magrath

  7. Special Considerations in Low and Middle Income Countries

    Article • August 2012, World Scientific Pub Co Pte Lt

    Professor Ian T Magrath

  8. Treatment of Burkitt lymphoma in equatorial Africa using a simple three‐drug combination followed by a salvage regimen for patients with persistent or recurrent disease

    Article • British Journal of Haematology, July 2012, Wiley

    Professor Ian T Magrath

  9. Epidemiology: clues to the pathogenesis of Burkitt lymphoma

    Article • British Journal of Haematology, January 2012, Wiley

    Professor Ian T Magrath

  10. Aggressive B-Cell Lymphomas

    Article • Advances in Hematology, January 2012, Hindawi Publishing Corporation

    Professor Ian T Magrath

  11. Towards Curative Therapy in Burkitt Lymphoma: The Role of Early African Studies in Demonstrating the Value of Combination Therapy and CNS Prophylaxis

    Article • Advances in Hematology, January 2012, Hindawi Publishing Corporation

    Professor Ian T Magrath

  12. Diagnosis of Burkitt lymphoma using an algorithmic approach – applicable in both resource‐poor and resource‐rich countries

    Article • British Journal of Haematology, July 2011, Wiley

    Professor Ian T Magrath

  13. Lymphomas in sub‐Saharan Africa – what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?

    Article • British Journal of Haematology, June 2011, Wiley

    Professor Ian T Magrath

  14. Childhood T-lineage acute lymphoblastic leukemia: Management and outcome at a tertiary care center in North India

    Article • Indian Pediatrics, March 2011, Springer Science + Business Media

    Professor Ian T Magrath

  15. Epidemiology and management of lymphoma in low‐income countries

    Article • Hematological Oncology, March 2011, Wiley

    Professor Ian T Magrath, Prof. Emanuele Zucca

  16. Cancer funding in developing countries: the next health-care crisis?

    Article • The Lancet, November 2010, Elsevier

    Professor Ian T Magrath

  17. The World Cancer Declaration: is the world catching up?

    Article • The Lancet Oncology, November 2010, Elsevier

    Professor Ian T Magrath

  18. The Lymphoid Neoplasms 3ed

    Article • July 2010, Taylor & Francis

    Professor Ian T Magrath

  19. Chronic lymphoid leukemias and μ heavy chain disease

    Article • July 2010, Taylor & Francis

    Professor Ian T Magrath

  20. Introduction to the lymphoid neoplasms

    Article • July 2010, Taylor & Francis

    Professor Ian T Magrath

  21. Historical perspective

    Article • July 2010, Taylor & Francis

    Professor Ian T Magrath

  22. Pattern of Relapse in Childhood ALL: Challenges and Lessons From a Uniform Treatment Protocol

    Article • Journal of Pediatric Hematology/Oncology, July 2010, Wolters Kluwer Health

    Professor Ian T Magrath

  23. Denis Burkitt and the African lymphoma

    Article • ecancermedicalscience, January 2010, Cancer Intelligence

    Professor Ian T Magrath

  24. Lessons from clinical trials in African Burkitt lymphoma

    Article • Current Opinion in Oncology, September 2009, Wolters Kluwer Health

    Professor Ian T Magrath

  25. It Is Time to Include Cancer and Other Noncommunicable Diseases in the Millennium Development Goals

    Article • CA A Cancer Journal for Clinicians, August 2009, Wiley

    Professor Ian T Magrath

  26. Outcomes of Patients With Burkitt Lymphoma Older Than Age 40 Treated With Intensive Chemotherapeutic Regimens

    Article • Clinical Lymphoma & Myeloma, August 2009, Elsevier

    Professor Ian T Magrath

  27. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study

    Article • The Lancet Oncology, August 2008, Elsevier

    Professor Ian T Magrath

  28. Non‐Hodgkin Lymphomas

    Article • December 2007, Wiley

    Professor Ian T Magrath

  29. Building capacity for cancer control in developing countries: the need for a paradigm shift

    Article • The Lancet Oncology, July 2007, Elsevier

    Professor Ian T Magrath

  30. Treatment of Burkitt lymphoma in children and adults: Lessons from Africa

    Article • Current Hematologic Malignancy Reports, December 2006, Springer Science + Business Media

    Professor Ian T Magrath

  31. High level expression of N-acetylgluosamine-6-O-sulfotransferase is characteristic of a subgroup of paediatric precursor-B acute lymphoblastic leukaemia

    Article • Cancer Letters, October 2006, Elsevier

    Professor Ian T Magrath

  32. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year peroid

    Article • European Journal of Cancer, July 2005, Elsevier

    Professor Ian T Magrath

  33. Frequent silencing of fragile histidine triad gene (FHIT) in Burkitt's lymphoma is associated with aberrant hypermethylation

    Article • Genes Chromosomes and Cancer, September 2004, Wiley

    Professor Ian T Magrath

  34. Modified Magrath Regimens for Adults with Burkitt and Burkitt-Like Lymphomas: Preserved Efficacy with Decreased Toxicity

    Article • Leukemia & Lymphoma, April 2004, Taylor & Francis

    Professor Ian T Magrath

  35. Differences in the Expression of Apoptotic Proteins in Burkitt's Lymphoma Cell Lines: Potential Models for Screening Apoptosis-Inducing Agents

    Article • Leukemia & Lymphoma, February 2004, Taylor & Francis

    Professor Ian T Magrath

  36. Chemotherapy in developing countries—is less better?

    Article • European Journal of Cancer, July 2003, Elsevier

    Professor Ian T Magrath

  37. Frequencies of the major subgroups of precursor B-cell acute lymphoblastic leukemia in Indian children differ from the West

    Article • Leukemia, May 2003, Springer Science + Business Media

    Professor Ian T Magrath

  38. Molecular Characteristics of Diffuse Large-B-Cell Lymphoma

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, June 2002, New England Journal of Medicine (NEJM/MMS)

    Professor Ian T Magrath

  39. Expression of P53 and Bcl-2 Proteins in T-cell Lymphoblastic Lymphoma: Prognostic Implications

    Article • Leukemia & Lymphoma, January 2002, Taylor & Francis

    Professor Ian T Magrath

  40. Editorial comment on detection of Epstein–Barr virus DNA in peripheral blood of paediatric patients with Hodgkin's disease by real-time polymerase chain reaction by Wagner and colleagues

    Article • European Journal of Cancer, October 2001, Elsevier

    Professor Ian T Magrath

  41. Burkitt's/Burkitt's-Like Lymphoma Presenting as Bacterial Sinusitis in Two HIV-Infected Children

    Article • AIDS Patient Care and STDs, September 2001, Mary Ann Liebert Inc

    Professor Ian T Magrath

  42. Incidence, clinical characteristics and early treatment outcome in Indian patients of childhood acute lymphoblastic leukemia with ALL-1 gene rearrangement

    Article • Leukemia Research, August 2001, Elsevier

    Professor Ian T Magrath

  43. Non-Hodgkin Lymphomas

    Article • June 2001, Wiley

    Professor Ian T Magrath

  44. Significance of MDR1, MRP1, GSTπ and GSTμ mRNA expression in acute lymphoblastic leukemia in Indian patients

    Article • Cancer Letters, June 2001, Elsevier

    Professor Ian T Magrath

  45. Pediatric oncology in developing countries: Development of an alliance of stakeholders

    Article • Medical and Pediatric Oncology, February 2001, Wiley

    Professor Ian T Magrath

  46. Expression of EBV Encoded Nuclear Small Non-Polyadenylated RNA (EBER) Molecules in 32 Cases of Childhood Burkitt's Lymphoma from Israel

    Article • Leukemia & Lymphoma, January 2001, Taylor & Francis

    Professor Ian T Magrath

  47. Pediatric oncology in developing countries: Development of an alliance of stakeholders

    Article • Medical and Pediatric Oncology, January 2001, Wiley

    Professor Ian T Magrath

  48. Impact of Chemotherapy for AIDS‐Related Malignancies in Pediatric HIV Disease

    Article • Annals of the New York Academy of Sciences, November 2000, Wiley

    Professor Ian T Magrath

  49. Pattern of immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements in childhood acute lymphoblastic leukemia in India

    Article • Leukemia Research, July 2000, Elsevier

    Professor Ian T Magrath

  50. Loss of Y Chromosome in Bilharzial Bladder Cancer

    Article • Cancer Genetics and Cytogenetics, February 2000, Elsevier

    Professor Ian T Magrath

  51. Molecular profile of Epstein–Barr virus infection in HHV-8-positive primary effusion lymphoma

    Article • Leukemia, January 2000, Springer Science + Business Media

    Professor Ian T Magrath

  52. Association of Burkitt's Lymphoma with the Epstein-Barr Virus in Two Developing Countries

    Article • Leukemia & Lymphoma, January 2000, Taylor & Francis

    Professor Ian T Magrath

  53. Breast Cancer: a New Epstein-Barr Virus-Associated Disease?

    Article • JNCI Journal of the National Cancer Institute, August 1999, Oxford University Press (OUP)

    Professor Ian T Magrath

  54. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: High prevalence of p53 overexpression

    Article • Human Pathology, July 1999, Elsevier

    Professor Ian T Magrath

  55. Comparative incidence of the rearrangements of TEL/AML1 and ALL1 genes in pediatric precursor B acute lymphoblastic leukemias in India.

    Article • International Journal of Oncology, December 1998, Spandidos Publications

    Professor Ian T Magrath

  56. Gene Therapy in the Treatment of Cancer

    Article • September 1998, Cambridge University Press

    Professor Ian T Magrath

  57. Preface

    Article • September 1998, Cambridge University Press

    Professor Ian T Magrath

  58. Introduction: gene therapy approaches to cancer

    Article • September 1998, Cambridge University Press

    Professor Ian T Magrath

  59. Precursor B-Lymphoblastic Lymphoma Presenting as a Solitary Bone Tumor and Mimicking Ewing's Sarcoma

    Article • The American Journal of Surgical Pathology, July 1998, Wolters Kluwer Health

    Professor Ian T Magrath

  60. p53 Expression in Langerhans Cell Histiocytosis

    Article • Journal of Pediatric Hematology/Oncology, January 1998, Wolters Kluwer Health

    Professor Ian T Magrath

  61. Limiting Therapy for Limited Childhood Non-Hodgkin's Lymphoma

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, October 1997, New England Journal of Medicine (NEJM/MMS)

    Professor Ian T Magrath

  62. Non-Hodgkin's Lymphomas: Epidemiology and Treatment

    Article • Annals of the New York Academy of Sciences, September 1997, Wiley

    Professor Ian T Magrath

  63. Expression of p53 in pediatric lymphomas from Mexico

    Article • International Journal of Oncology, September 1997, Spandidos Publications

    Professor Ian T Magrath

  64. NON-HODGKIN'S LYMPHOMA

    Article • Pediatric Clinics of North America, August 1997, Elsevier

    Professor Ian T Magrath

  65. RESULTS OF A TREATMENT PROTOCOL FOR CHILDREN WITH HIV AND NON-HODGKIN'S LYMPHOMAS (NHLS).

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, April 1997, Wolters Kluwer Health

    Professor Ian T Magrath

  66. The treatment of pediatric lymphomas: Paradigms to plagiarize?

    Article • Annals of Oncology, January 1997, Oxford University Press (OUP)

    Professor Ian T Magrath

  67. 5 Management of histologically aggressive lymphomas with a high risk of CNS disease

    Article • Baillière s Clinical Haematology, December 1996, Elsevier

    Professor Ian T Magrath

  68. Combination chemotherapy for advanced bilharzial bladder carcinoma

    Article • Annals of Oncology, September 1996, Oxford University Press (OUP)

    Professor Ian T Magrath

  69. Use of Epstein-Barr Virus Nuclear Antigen-1 in Targeted Therapy of EBV-Associated Neoplasia

    Article • Human Gene Therapy, March 1996, Mary Ann Liebert Inc

    Professor Ian T Magrath

  70. Treatment of Patients with High Grade Non-Hodgkin's Lymphomas and Central Nervous System Involvement: Is Radiation an Essential Component of Therapy?

    Article • Leukemia & Lymphoma, January 1996, Taylor & Francis

    Professor Ian T Magrath

  71. P53 MUTATIONS IN EGYPTIAN BLADDER-CANCER

    Article • International Journal of Oncology, December 1995, Spandidos Publications

    Professor Ian T Magrath

  72. 1241 Impact of improved supportive care on treatment outcome in acute lymphoblastic leukemia—an indian experience

    Article • European Journal of Cancer, November 1995, Elsevier

    Professor Ian T Magrath

  73. The investigation of epstein–barr viral sequences in 41 cases of Burkitt's lymphoma from Egypt. Epidemiologic correlations

    Article • Cancer, October 1995, Wiley

    Professor Ian T Magrath

  74. Bone-marrow transplantation

    Article • The Lancet, July 1995, Elsevier

    Professor Ian T Magrath

  75. Bone marrow transplantation for leukaemia: a lame stalking horse for use of high-technology medical care

    Article • The Lancet, March 1995, Elsevier

    Professor Ian T Magrath

  76. Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive Chemotherapy

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, January 1995, New England Journal of Medicine (NEJM/MMS)

    Professor Ian T Magrath

  77. Elevated levels of p53 protein in adrenocortical carcinomas from Costa Rica

    Article • European Journal of Cancer, January 1995, Elsevier

    Professor Ian T Magrath

  78. Mutations in the Coding Region of c-myc Occur Independently of Mutations in the Regulatory Regions and are Predominantly Associated with myc/lg Translocation

    Article • January 1995, Springer Science + Business Media

    Professor Ian T Magrath

  79. BOOK REVIEW

    Article • JNCI Journal of the National Cancer Institute, October 1994, Oxford University Press (OUP)

    Professor Ian T Magrath

  80. Binding and suppression of the Myc transcriptional activation domain by p107

    Article • Science, April 1994, American Association for the Advancement of Science

    Professor Ian T Magrath

  81. PROGNOSTIC-SIGNIFICANCE OF P53 MUTATIONS IN SMALL NON-CLEAVED CELL LYMPHOMAS

    Article • International Journal of Oncology, March 1994, Spandidos Publications

    Professor Ian T Magrath

  82. Targeted approaches to cancer therapy: Meeting held at stone house, NIH, bethesda, md, January 11–12, 1993

    Article • International Journal of Cancer, January 1994, Wiley

    Professor Ian T Magrath

  83. Adult Acute Lymphoblastic Leukemia: Results of an Aggressive Regimen in India

    Article • Leukemia & Lymphoma, January 1994, Taylor & Francis

    Professor Ian T Magrath

  84. Prospects for the therapeutic use of antisense oligonucleotides in malignant lymphomas

    Article • Annals of Oncology, January 1994, Oxford University Press (OUP)

    Professor Ian T Magrath

  85. A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors

    Article • Human Molecular Genetics, January 1994, Oxford University Press (OUP)

    Professor Ian T Magrath

  86. Infection Analysis in Acute Lymphoblastic Leukemia: A Report of 499 Consecutive Episodes in India

    Article • Pediatric Hematology and Oncology, January 1994, Taylor & Francis

    Professor Ian T Magrath

  87. Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas

    Article • Nature Genetics, September 1993, Springer Science + Business Media

    Professor Ian T Magrath

  88. Cancer in Developing Countries: Opportunity and Challenge

    Article • JNCI Journal of the National Cancer Institute, June 1993, Oxford University Press (OUP)

    Professor Ian T Magrath

  89. MOLECULAR CHARACTERIZATION OF SCL REARRANGEMENTS IN T-CELL ALL FROM INDIA AND EGYPT

    Article • International Journal of Oncology, May 1993, Spandidos Publications

    Professor Ian T Magrath, Professor Azza M Kamel

  90. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies

    Article • Leukemia Research, March 1993, Elsevier

    Professor Ian T Magrath

  91. The role of gallium-67 tumour scintigraphy in patients with small, non-cleaved cell lymphoma

    Article • European Journal of Pediatrics, February 1993, Springer Science + Business Media

    Professor Ian T Magrath

  92. Heterotransplantation of Human Burkitt’s Lymphoma Cell Lines in Athymic Nude Mice: Tumor-Host Relationships

    Article • Pathobiology, January 1993, Karger Publishers

    Professor Ian T Magrath

  93. Burkitt's lymphoma between African and American types in Turkish children: Clinical, viral (EBV), and molecular studies

    Article • Medical and Pediatric Oncology, January 1993, Wiley

    Professor Ian T Magrath, Prof Nejat Akar

  94. PCR detection of a neutral CGA/CGG dimorphism in exon 6 of the human p53 gene

    Article • Nucleic Acids Research, January 1992, Oxford University Press (OUP)

    Professor Ian T Magrath

  95. A novel mutation in the p53 gene in a Burkitt's lymphoma cell line

    Article • Human Molecular Genetics, January 1992, Oxford University Press (OUP)

    Professor Ian T Magrath

  96. Burkitt’s Lymphoma Cells Frequently Carry Monoallelic DJ Rearrangements

    Article • January 1992, Springer Science + Business Media

    Professor Ian T Magrath

  97. A chemiluminescent assay for quantitation of β-galactosidase in the femtogram range: Application to quantitation of β-galactosidase in lacZ-transfected cells

    Article • Analytical Biochemistry, November 1991, Elsevier

    Professor Ian T Magrath

  98. Ifosfamide in the treatment of high‐grade recurrent non‐hodgkin's lymphomas

    Article • Hematological Oncology, July 1991, Wiley

    Professor Ian T Magrath

  99. Prolonged disease‐free survival in pediatric non‐hodgkin's lymphoma using ifosfamide‐containing combination chemotherapy

    Article • Hematological Oncology, July 1991, Wiley

    Professor Ian T Magrath

  100. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

    Article • Proceedings of the National Academy of Sciences, June 1991, Proceedings of the National Academy of Sciences

    Professor Ian T Magrath

  101. Workshop on pediatric lymphomas: Current results and prospects

    Article • Annals of Oncology, February 1991, Oxford University Press (OUP)

    Professor Ian T Magrath

  102. Workshop on pediatric lymphomas: Current results and prospects

    Article • January 1991, Springer Science + Business Media

    Professor Ian T Magrath

  103. African Burkittʼs Lymphoma

    Article • Journal of Pediatric Hematology/Oncology, January 1991, Wolters Kluwer Health

    Professor Ian T Magrath

  104. Inhibition of the EBV Lytic Cycle by Sequence Specific Antisense Oligonucleotides

    Article • January 1991, Springer Science + Business Media

    Professor Ian T Magrath

  105. Advances in the Understanding of EBV Associated Lymphoproliferative Disorders

    Article • January 1991, Springer Science + Business Media

    Professor Ian T Magrath

  106. Identification of p53 gene abnormalities in acute lymphoblastic leukemia of childhood

    Article • Journal of Pediatric Hematology/Oncology, January 1991, Wolters Kluwer Health

    Professor Ian T Magrath

  107. Neo-Adjuvant chemotherapy : Epirubicin in invasive bladder cancer ; four-year follow-up

    Article • January 1991, Springer Science + Business Media

    Professor Ian T Magrath

  108. Book Review The Non-Hodgkin's Lymphomas Edited by Ian T. Magrath. 430 pp., illustrated. Baltimore, Williams and Wilkins, 1990. $72.50.

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1990, New England Journal of Medicine (NEJM/MMS)

    Professor Ian T Magrath

  109. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide

    Article • The Lancet, April 1990, Elsevier

    Professor Ian T Magrath

  110. The Pathogenesis of Burkitt's Lymphoma

    Article • January 1990, Elsevier

    Professor Ian T Magrath

  111. Phenotypic analysis of T-cell acute lymphoblastic leukemia in Egypt

    Article • Leukemia Research, January 1990, Elsevier

    Professor Ian T Magrath, Professor Azza M Kamel

  112. Relative Predispositional Effect of a PADPRP Marker Allele in B-Cell and Some Non B-Cell Malignancies

    Article • January 1990, Springer Science + Business Media

    Professor Ian T Magrath

  113. Immunoglobulin Delta Expression in Burkitt's Lymphoma Cell Lines

    Article • JNCI Journal of the National Cancer Institute, July 1989, Oxford University Press (OUP)

    Professor Ian T Magrath

  114. Childhood non-Hodgkin's lymphoma in Egypt: preliminary results of treatment with a new ifosfamide-containing regimen

    Article • Cancer Chemotherapy and Pharmacology, July 1989, Springer Science + Business Media

    Professor Ian T Magrath

  115. BOOK REVIEWS

    Article • JNCI Journal of the National Cancer Institute, February 1989, Oxford University Press (OUP)

    Professor Ian T Magrath

  116. New Directions in Cancer Treatment

    Article • January 1989, Springer Science + Business Media

    Professor Ian T Magrath

  117. Infectious Mononucleosis and Malignant Neoplasia

    Article • January 1989, Springer Science + Business Media

    Professor Ian T Magrath

  118. Immunological sub types of Egyptian acute lymphoblastic leukemia

    Article • Leukemia Research, January 1989, Elsevier

    Professor Ian T Magrath, Professor Azza M Kamel

  119. Bone marrow involvement in young patients with non‐Hodgkin's lymphoma: The importance of multiple bone marrow samples for accurate staging

    Article • Medical and Pediatric Oncology, January 1989, Wiley

    Professor Ian T Magrath

  120. Childhood Non-Hodgkin’s Lymphomas

    Article • January 1989, Springer Science + Business Media

    Professor Ian T Magrath

  121. New Directions in Cancer Treatment: An Overview

    Article • January 1989, Springer Science + Business Media

    Professor Ian T Magrath

  122. Prospects for the Development of Antineoplastic Therapy Based on Molecular Pathology

    Article • January 1989, Springer Science + Business Media

    Professor Ian T Magrath

  123. The molecular analysis of chromosomal translocations as a diagnostic, epidemiological and potentially prognostic tool in lymphoid neoplasia

    Article • Journal of Virological Methods, September 1988, Elsevier

    Professor Ian T Magrath

  124. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma.

    Article • Proceedings of the National Academy of Sciences, April 1988, Proceedings of the National Academy of Sciences

    Professor Ian T Magrath

  125. Testicular Involvement in Young Patients with Non-Hodgkinʼs Lymphoma

    Article • Journal of Pediatric Hematology/Oncology, January 1988, Wolters Kluwer Health

    Professor Ian T Magrath

  126. Significance of Chromosome 8 Breakpoint Location in Burkitt’s Lymphoma: Correlation with Geographical Origin and Association with Epstein-Barr Virus

    Article • January 1988, Springer Science + Business Media

    Professor Ian T Magrath

  127. Immunogenetics Immunogenetics: Its Application to Clinical Medicine Takehiko Sasazuki Tomio Tadi

    Article • BioScience, March 1987, JSTOR

    Professor Ian T Magrath

  128. Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma.

    Article • Proceedings of the National Academy of Sciences, May 1986, Proceedings of the National Academy of Sciences

    Professor Ian T Magrath

  129. Treatment of recurrent sarcomas and pediatric solid tumors with ifosfamide (IF)

    Article • Journal of Cancer Research and Clinical Oncology, February 1986, Springer Science + Business Media

    Professor Ian T Magrath

  130. Characterization of Burkitt’s Lymphoma Cell Lines with Monoclonal Antibodies Using an ELISA Technique

    Article • January 1986, Springer Science + Business Media

    Professor Ian T Magrath

  131. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people

    Article • Cancer Chemotherapy and Pharmacology, January 1986, Springer Science + Business Media

    Professor Ian T Magrath

  132. Very high dose cyclophosphamide with imidazole carboximide and vineristine sulf ate in the treatment of Stasre IV neuroblastoma

    Article • American Journal of Clinical Oncology, June 1985, Wolters Kluwer Health

    Professor Ian T Magrath

  133. Myelopathy following intrathecal chemotherapy in a patient with extensive burkitt's lymphoma and altered immune status

    Article • The American Journal of Medicine, April 1985, Elsevier

    Professor Ian T Magrath

  134. Clinical and Pathobiological Features of Burkitt’s Lymphoma and their Relevance to Treatment

    Article • January 1985, Springer Science + Business Media

    Professor Ian T Magrath

  135. Chromosomal orientation of the lambda light chain locus: Vλ is proximal to Cλ in 22q11

    Article • Nucleic Acids Research, January 1985, Oxford University Press (OUP)

    Professor Ian T Magrath

  136. Characteristics and results of treatment of non-Hodgkin’s lymphoma in young people — Experience of the Pediatric Branch, NCI, USA

    Article • January 1985, Springer Science + Business Media

    Professor Ian T Magrath

  137. HIGH‐GRADE NON‐HODGKIN'S LYMPHOMA IN PATIENTS WITH AIDSa

    Article • Annals of the New York Academy of Sciences, December 1984, Wiley

    Professor Ian T Magrath

  138. Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations.

    Article • Proceedings of the National Academy of Sciences, June 1984, Proceedings of the National Academy of Sciences

    Professor Ian T Magrath

  139. Jaw involvement in American Burkitt's lymphoma

    Article • Cancer, April 1984, Wiley

    Professor Ian T Magrath

  140. Burkitt’s Lymphoma: Clinical Aspects and Treatment

    Article • January 1984, Springer Science + Business Media

    Professor Ian T Magrath

  141. Synthesis of kappa light chains by cell lines containing an 8;22 chromosomal translocation derived from a male homosexual with Burkitt's lymphoma

    Article • Science, December 1983, American Association for the Advancement of Science

    Professor Ian T Magrath

  142. Gastric manifestations of North American Burkitt's lymphoma

    Article • British Journal of Radiology, October 1983, British Institute of Radiology

    Professor Ian T Magrath

  143. Fluorescence polarization as a parameter of plasma lipids in patients with hematologic malignancies

    Article • Leukemia Research, January 1983, Elsevier

    Professor Ian T Magrath

  144. Undifferentiated lymphoma cells respond to PWM in the presence of theophylline or helper T cells

    Article • Clinical Immunology and Immunopathology, December 1982, Elsevier

    Professor Ian T Magrath

  145. Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: Implications for the relationship between African and American Burkitt's lymphoma

    Article • Clinical Immunology and Immunopathology, October 1982, Elsevier

    Professor Ian T Magrath

  146. The Role of Surgery in the Management of American Burkittʼs Lymphoma and Its Treatment

    Article • Annals of Surgery, July 1982, Wolters Kluwer Health

    Professor Ian T Magrath

  147. Plasma lipid alterations in leukemia and lymphoma

    Article • The American Journal of Medicine, May 1982, Elsevier

    Professor Ian T Magrath

  148. The American Burkitt's lymphoma registry:Eight years' experience

    Article • Cancer, March 1982, Wiley

    Professor Ian T Magrath

  149. Burkitt cell leukemia without abnormalities of chromosomes No. 8 and 14

    Article • Cancer Genetics and Cytogenetics, February 1982, Elsevier

    Professor Ian T Magrath

  150. HYPOTHESIS: THE ENVIRONMENT IS A MAJOR DETERMINANT OF THE IMMUNOLOGICAL SUB‐TYPE OF LYMPHOMA AND ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDREN

    Article • British Journal of Haematology, February 1982, Wiley

    Professor Ian T Magrath

  151. Renal and Metabolic Complications of Undifferentiated and Lymphoblastic Lymphomas

    Article • Medicine, May 1981, Wolters Kluwer Health

    Professor Ian T Magrath

  152. CT of American Burkitt lymphoma

    Article • American Journal of Roentgenology, April 1981, American Roentgen Ray Society

    Professor Ian T Magrath

  153. The Epstein-Barr Virus. M. A. Epstein B. G. Achong

    Article • The Quarterly Review of Biology, December 1980, University of Chicago Press

    Professor Ian T Magrath

  154. Long‐term experience with burkitt's lymphoma in uganda

    Article • International Journal of Cancer, September 1980, Wiley

    Professor Ian T Magrath

  155. B Cell Differentiation and Immunoregulatory T Cell Function in Human Cord Blood Lymphocytes

    Article • Journal of Clinical Investigation, August 1980, American Society for Clinical Investigation

    Professor Ian T Magrath

  156. Acute tumor lysis syndrome

    Article • The American Journal of Medicine, April 1980, Elsevier

    Professor Ian T Magrath

  157. Prognostic factors in Burkitt's lymphoma importance of total tumor burden

    Article • Cancer, March 1980, Wiley

    Professor Ian T Magrath

  158. Bone marrow involvement in Burkitt's lymphoma and its relationship to acute B-cell leukemia

    Article • Leukemia Research, January 1980, Elsevier

    Professor Ian T Magrath

  159. Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, November 1979, New England Journal of Medicine (NEJM/MMS)

    Professor Ian T Magrath

  160. CURE OF BURKITT'S LYMPHOMA Ten-year Follow-up of 157 Ugandan Patients

    Article • The Lancet, November 1979, Elsevier

    Professor Ian T Magrath

  161. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids

    Article • Virology, September 1979, Elsevier

    Professor Ian T Magrath

  162. Ultrasound evaluation of american burkitt's lymphoma

    Article • Journal of Clinical Ultrasound, August 1979, Wiley

    Professor Ian T Magrath

  163. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

    Article • The American Journal of Medicine, August 1979, Elsevier

    Professor Ian T Magrath

  164. Tumor lysis pancreatitis

    Article • Medical and Pediatric Oncology, January 1979, Wiley

    Professor Ian T Magrath

  165. Childhood Hodgkin's disease in Uganda.A ten year experience

    Article • Cancer, August 1978, Wiley

    Professor Ian T Magrath

  166. A new tumour-derived transforming strain of Epstein–Barr virus

    Article • Nature, April 1978, Springer Science + Business Media

    Professor Ian T Magrath

  167. Fc IgM receptors on human lymphoblastoid B cell lines

    Article • European Journal of Immunology, April 1978, Wiley

    Professor Ian T Magrath

  168. Hypercalcemia with suppressed parathyroid hormone in Burkitt's lymphoma

    Article • The American Journal of Medicine, April 1978, Elsevier

    Professor Ian T Magrath

  169. Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse

    Article • Cancer, March 1978, Wiley

    Professor Ian T Magrath

  170. Immunosuppression in burkitt's lymphoma. II. Peripheral blood lymphocyte populations related to clinical status

    Article • International Journal of Cancer, October 1976, Wiley

    Professor Ian T Magrath

  171. Treatment of Burkitt's lymphoma: Randomized clinical trial of single‐agent versus combination chemotherapy

    Article • International Journal of Cancer, April 1976, Wiley

    Professor Ian T Magrath

  172. Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.

    Article • BMJ, March 1976, BMJ

    Professor Ian T Magrath

  173. Antibodies to Epstein–Barr-Virus Antigens before and after the Development of Burkitt's Lymphoma in a Patient Treated for Hodgkin's Disease

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 1975, New England Journal of Medicine (NEJM/MMS)

    Professor Ian T Magrath

  174. HL–A and Burkitt's Tumour – A Study in Uganda

    Article • Tissue Antigens, January 1975, Wiley

    Professor Ian T Magrath

  175. CHEMOTHERAPY OF HODGKIN'S DISEASE

    Article • The Lancet, December 1974, Elsevier

    Professor Ian T Magrath

  176. Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)

    Article • Cancer, October 1974, Wiley

    Professor Ian T Magrath

  177. Immunosuppression in Burkitt's lymphoma. I. Cutaneous reactivity to recall antigens: Alterations induced by a tumour burden and by BCG administration

    Article • International Journal of Cancer, June 1974, Wiley

    Professor Ian T Magrath

  178. Surgical Reduction of Tumour Bulk in Management of Abdominal Burkitt's Lymphoma

    Article • BMJ, May 1974, BMJ

    Professor Ian T Magrath

  179. Burkitt's lymphoma: a B or T cell tumour?

    Article • European Journal of Cancer (1965), February 1974, Elsevier

    Professor Ian T Magrath

  180. Preliminary Results of a Randomized Trial of BCG Immunotherapy in Burkitt’s Lymphoma

    Article • January 1974, Springer Science + Business Media

    Professor Ian T Magrath

  181. Burkitt's Tumors Contain Particles Encapsulating RNA-Instructed DNA Polymerase and High Molecular Weight Virus-Related RNA

    Article • Proceedings of the National Academy of Sciences, March 1973, Proceedings of the National Academy of Sciences

    Professor Ian T Magrath

  182. Skin ulceration caused by Salmonella dublin.

    Article • BMJ, February 1973, BMJ

    Professor Ian T Magrath

  183. Standardization of the Leucocyte Migration Test

    Article • International Archives of Allergy and Immunology, January 1973, Karger Publishers

    Professor Ian T Magrath

  184. Intensive chemotherapy in patients with generalized Burkitt's lymphoma

    Article • International Journal of Cancer, September 1972, Wiley

    Professor Ian T Magrath

  185. CHEMOTHERAPY OF CHILDHOOD HODGKIN'S DISEASE IN UGANDA

    Article • The Lancet, September 1972, Elsevier

    Professor Ian T Magrath

  186. Survival of candida septicaemia treated with amphotericin B

    Article • Postgraduate Medical Journal, July 1972, Oxford University Press (OUP)

    Professor Ian T Magrath

  187. Medical Presentations of Choriocarcinoma

    Article • BMJ, June 1971, BMJ

    Professor Ian T Magrath

  188. INTRATHECAL METHOTREXATE

    Article • The Lancet, December 1969, Elsevier

    Professor Ian T Magrath

  189. Principles of transformation-directed cancer therapy

    Article • Cambridge University Press

    Professor Ian T Magrath

  190. Vectors for cancer gene therapy

    Article • Cambridge University Press

    Professor Ian T Magrath

  191. B-Cell Lymphoma/Burkitt Lymphoma

    Article • Springer Science + Business Media

    Professor Ian T Magrath